PACLITAXEL(T), ESTRAMUSTINE(E) AND CARBOPLATIN(C) IN PATIENTS (Pts) WITH ADVANCED PROSTATE CANCER(PC):

K. Kelly,P. Gaudin,S. Slovin,T. Curley,J. McCaffrey,Allison L. Ciolino,G. Dalbagni,S. Donat,P. Scardino,H. Scher,P. Kantoff,Matthew R. Smith,W. Oh,D. E. Smith,E. Small

Published 1999 in The Journal of Urology

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
1999
Venue
The Journal of Urology
Publication date
1999-04-01
Fields of study
Medicine
Identifiers
DOI 10.1097/00005392-199904010-00711
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

No references are available for this paper.

CITED BY

Treatment options in hormone resistant prostate cancer.
2002cites this paper
HER‐2 profiling and targeting in prostate carcinoma
2002cites this paper
Paclitaxel and docetaxel in prostate cancer.
2001cites this paper
Chemotherapy for androgenindependent prostate cancer: Myth or reality
2000cites this paper
Chemotherapy for patients with advanced prostate carcinoma
2000cites this paper
Treatment of locally advanced prostate cancer: is chemotherapy the next step?
1999cites this paper